See Today's Golden Star Stocks 🔥 Free for 7 Days See Today's Golden Star Stocks 🔥 Free for 7 Days
News Digest / StockInvest.us

Author: StockInvest.us
08:06am, Thursday, May 15, 2025
Invivyd Reports First Product Revenue as Losses Decline, Yet Faces Long-Term Financial Concerns
Company Overview: Invivyd, Inc. (NASDAQ: IVVD) is focused on developing monoclonal antibodies (mAbs) for serious viral infectious diseases, primarily COVID-19 through its product PEMGARDA™ (pemivibart). Key Financial Highlights: Revenue: Product revenue for Q1 2025 reached $11.3 million, marking...
Read More